Avilex Pharma

Avilex Pharma develops novel inhibitors of PDZ domain proteins to target a range of unmet medical needs with a lead drug candidate AVLX-144 for the treatment of ischemic stroke.

Contact name:

Kristian Strømgaard

Address:

Ole Maaløes Vej 3, 2200 Copenhagen N, Denmark

Number of employees:

3

If you cannot find what you are looking for or if you have feedback to our website, please do not hesitate to contact dd@danskbiotek.dk or +45 5150 0560

Copyright 2015 DANISH BIO – DANSK BIOTEK. All rights reserved.